BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Pappas Ventures Names Eric Linsley Managing Partner
News | 09. 28. 2009
Pappas Ventures today announced that Eric W. Linsley has been promoted to Managing Partner.
